BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 21, 2017
View Archived Issues
Opiant reports phase I data on OPNT-002
Read More
JCR and Teijin partner on allogeneic regenerative medical product JTR-161 for stroke in Japan
Read More
Bioniz reports topline results from first-in-human study of BNZ-1
Read More
Emergent to acquire raxibacumab from GSK
Read More
Intranasal treatment with CYP-001 offers antiremodeling effects in mouse models of chronic asthma
Read More
FDA grants rare pediatric disease designation to Spark Therapeutics' Luxturna
Read More
Roche to end involvement in development of ORY-1001
Read More
Mutations in TMEM8C gene found to cause Carey-Fineman-Ziter syndrome
Read More
FDA grants orphan drug designation to gilteritinib for AML
Read More
FDA accepts for review Yonsa NDA for metastatic castration-resistant prostate cancer
Read More
FDA grants tentative approval for follow-on biologic basal insulin Lusduna Nexvue
Read More
Vitae Pharmaceuticals discloses menin/MLL interaction inhibitors
Read More
Shionogi & Co. patents MGAT2 inhibitors
Read More
Incyte treats first patient in phase III trial of itacitinib in acute graft-versus-host disease
Read More
U.S. phase II trial of T-817MA in mild to moderate Alzheimer's disease misses primary endpoints
Read More
ORIC Pharmaceuticals divulges glucocorticoid receptor antagonists
Read More
Merck & Co. discovers viral genome polyprotein inhibitors
Read More
Otsuka Pharmaceutical Factory identifies lipoprotein lipase activators
Read More
European Commission approves Veltassa to treat hyperkalemia
Read More
FDA accepts for review Aimovig BLA for migraine prevention
Read More
Kamada submits inhaled AAT phase III protocol to FDA for review
Read More
Novel F7 gene mutations identified in inherited FVII deficiency
Read More
NICE approves use of Kyprolis through English NHS
Read More
NICE recommends use of Cinqaero through English NHS
Read More
Phase II trial of Twin for acne achieved primary and secondary efficacy endpoints
Read More
BiondVax reports phase IIb data on universal flu vaccine candidate M-001
Read More
CIRM grant to support Brainstorm's planned phase III study of NurOwn for ALS
Read More
European Commission approves Dompe's cenegermin eye drops for neurotrophic keratitis
Read More
BAY-386, a novel PAR1 receptor inhibitor for arterial thrombosis
Read More
Ironwood reports topline phase IIb data on IW-3718 in uncontrolled GERD
Read More
Auris Medical completes acquisition of intranasal betahistine assets from Otifex Therapeutics
Read More